[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q3_USD":3017789.0,"NetIncomeLoss_3_Q3_USD":-3508199.0,"OperatingIncomeLoss_1_Q3_USD":-2556742.0,"OperatingIncomeLoss_3_Q3_USD":-4084445.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":1030180.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":576246.0,"PaymentsForProceedsFromDepositOnLoan_3_Q3_USD":300000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":237197.0,"PaymentsToInvestInDecommissioningFund_3_Q3_USD":207000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"PreferredStockSharesIssued_0_Q3_shares":null,"PreferredStockSharesOutstanding_0_Q3_shares":null,"PreferredStockValue_0_Q3_USD":null,"PrepaidExpenseCurrent_0_Q3_USD":698309.0,"ProceedsFromIssuanceOfWarrants_3_Q3_USD":2000000.0,"ProceedsFromRelatedPartyDebt_3_Q3_USD":500000.0,"ProfitLoss_1_Q3_USD":-1526562.0,"PublicUtilitiesApprovedReturnOnEquityPercentage_3_Q3_pure":0.2,"RepaymentsOfRelatedPartyDebt_3_Q3_USD":300000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-16112484.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice_0_Q3_USD":11.5,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.163,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.0107,"SharesIssuedPricePerShare_0_Q3_USD":10.0,"StockholdersEquity_0_Q3_USD":-16111966.0,"TemporaryEquityAccretionToRedemptionValue_3_Q3_USD":12626239.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":207000000.0,"NetIncomeLoss_1_Q3_USD":-1526562.0,"UnrealizedGainLossOnDerivatives_1_Q3_USD":1027000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1717314.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":208718803.0,"Assets_0_Q3_USD":207865392.0,"AssetsCurrent_0_Q3_USD":856646.0,"AssetsHeldInTrust_0_Q3_USD":1002.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":207008746.0,"Cash_0_Q3_USD":158000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":158337.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_3_Q3_USD":1489.0,"CommitmentsAndContingencies_0_Q3_USD":null,"DebtConversionConvertedInstrumentRate_3_Q3_pure":0.2,"DebtInstrumentRedemptionPricePercentage_3_Q3_pure":0.02,"DeferredCompensationLiabilityClassifiedNoncurrent_0_Q3_USD":null,"DueToRelatedPartiesCurrent_0_Q3_USD":500000.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_1_Q3_pure":0.0,"EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_3_Q3_pure":0.0,"GainLossOnSaleOfDerivatives_1_Q3_USD":null,"GainLossOnSaleOfDerivatives_3_Q3_USD":-1272500.0,"GeneralAndAdministrativeExpense_1_Q3_USD":2556742.0,"GeneralAndAdministrativeExpense_3_Q3_USD":4084445.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":3015261.0,"IncreaseDecreaseInPrepaidExpensesOther_3_Q3_USD":698309.0,"InterestIncomeSecuritiesOtherUSGovernment_1_Q3_USD":3180.0,"InterestIncomeSecuritiesOtherUSGovernment_3_Q3_USD":8746.0,"InvestmentIncomeInterest_3_Q3_USD":8746.0,"Liabilities_0_Q3_USD":16977358.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":207865392.0,"LiabilitiesCurrent_0_Q3_USD":3636358.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":207007744.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-207000000.0,"UnrealizedGainLossOnDerivatives_3_Q3_USD":1840000.0,"Ticker":"GRNA","CIK":"1822691","name":"ENVIRONMENTAL IMPACT ACQUISITION CORP","OfficialName":"GreenLight Biosciences Holdings PBC Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1030624353.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211112"}]